Open AccessA systematic review of infliximab in the treatment of early rheumatoid arthritis
Author(s) -
Axel Finckh
Publication year - 2007
Publication title -
therapeutics and clinical risk management
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.719
H-Index - 55
eISSN - 1178-203X
pISSN - 1176-6336
DOI - 10.2147/tcrm.s988
Subject(s) - medicine , infliximab , rheumatoid arthritis , placebo , methotrexate , randomized controlled trial , prednisone , clinical trial , disease , surgery , alternative medicine , pathology
Several health authorities have recently revised the indication of infliximab (IFX) to include the treatment of early rheumatoid arthritis (RA). The aim of this systematic review of the literature was to appraise the efficacy, safety, and cost-effectiveness of early therapy with IFX.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom